Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by JDavenporton Apr 06, 2022 2:27pm
61 Views
Post# 34581517

RE:RE:RE:RE:RE:RE:RE:After 14 years, GET AN IND SUBMISSION IN TO THE FDA!!

RE:RE:RE:RE:RE:RE:RE:After 14 years, GET AN IND SUBMISSION IN TO THE FDA!!No, Sdpp, I've been giving you a large number of reasons for the deadline and its possible meanings because we don't know what the deadline is for.

On the other hand, you don't consider any of the possibilities. You are posting expectations of news without consideration of the various things that could be going on.

You expect news. (You say!)

But in reality, you're setting a deadline trap. After setting this up and if the day passes without news, you're basically advising investors that there's a problem when there could actually be some fantastic things in play as a result of the Daiichi Sankyo work.

Your thinking is narrow to the point that malice must be considered, Sdpp.

Deadline trap...

jd
<< Previous
Bullboard Posts
Next >>